Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Sharps Compliance reports revenue of $4.2M for fourth-quarter fiscal 2010

Sharps Compliance Corp., a leading full-service provider of cost-effective management solutions for medical waste and unused dispensed medications generated outside the hospital and large healthcare facility setting, today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.

10 Aug 2010

Three-year efficacy data on STELARA for psoriasis presented at American Academy of Dermatology meeting

New study findings showed that a majority of patients with moderate to severe plaque psoriasis who had a previous response to STELARA® (ustekinumab) sustained a clinical response for up to three years with continued treatment regardless of their body weight. Investigators also presented findings from an integrated safety analysis that included data from one Phase 2 and three Phase 3 trials in which treatment with STELARA demonstrated a favorable benefit-risk profile for up to three years of treatment, consistent with previous analyses.

10 Aug 2010

NIH begins human clinical testing for dengue virus vaccine

After more than a decade of development at the National Institutes of Health, a vaccine to prevent infection by the mosquito-borne dengue virus has begun human clinical testing. The vaccine was developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) and is undergoing clinical study at the Johns Hopkins Bloomberg School of Public Health in Baltimore.

10 Aug 2010

H1N1 pandemic could be declared over soon, WHO's Chan says

The WHO's decision to declare the H1N1 (swine flu) pandemic officially over could come within weeks, according to WHO Director-General Margaret Chan, the Canadian Press reports.

10 Aug 2010

Study suggests reimbursements can address inappropriate antibiotic usage

Antibiotic use appears to have increased among older adults whose prescription drug coverage improved as a result of enrolling in Medicare Part D, with the largest increases for broad-spectrum, newer and more expensive drugs, according to a report in the August 9/23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

10 Aug 2010

Private sleuths take time referring fraud cases to Medicare

The Associated Press: While President Barack Obama "has set a high priority on battling health care fraud and waste" in Medicare, private contractors are slow in referring cases to law enforcement. "According to congressional investigators, the exact average was 178 days [to refer the case for prosecution].

10 Aug 2010

Isis second-quarter pro forma net operating loss increases to $15.5 million

Isis Pharmaceuticals, Inc. today announced its financial results for the quarter ended June 30, 2010. The Company finished the second quarter of 2010 with a pro forma net operating loss (NOL) of $15.5 million and $17.1 million for the three and six months ended June 30, 2010, respectively, compared to a pro forma net operating loss of $1.3 million and pro forma net operating income of $798,000 for the same periods of 2009.

9 Aug 2010

First Edition: August 9, 2010

Today's health policy headlines include dispatches from the campaign trail, news of the President's weekly address and developments from the health care marketplace.

9 Aug 2010

U.S. TSA designates BioStorage Technologies as Certified Cargo Screening Facility

BioStorage Technologies, a global leader in sample management and cold-chain logistics for the pharma and biotech industries, has recently been approved as a Certified Cargo Screening Facility (CCSF) by the U.S. Transportation Security Administration (TSA). The designation establishes BioStorage Technologies as one of the few sample management providers to achieve this clearance level, which allows the company to pre-screen shipments at its facility, thereby avoiding possible screening delays at the airport.

7 Aug 2010

Hemispherx Biopharma second-quarter net loss decreases to $3.67 million

Hemispherx Biopharma, Inc. announced its financial results for the three months ended June 30, 2010. The net loss (including non-cash expenses) for the 2nd fiscal quarter was approximately $3,676,000 or $0.03 per share compared to a loss of approximately $3,870,000 or $0.04 per share for the same period in 2009.

7 Aug 2010

Cornerstone announces ANDA filing for generic Tussionex

Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its product candidate CRTX-067 is an ANDA filing for a generic 10 mg chlorpheniramine polistirex/8 mg hydrocodone polistirex suspension product that will be a generic substitute for the product currently sold under the Tussionex brand name by UCB, Inc.

7 Aug 2010

Novavax reports net loss of $9.4M for second-quarter 2010

Novavax, Inc. today announced financial results for the second quarter ended June 30, 2010.

7 Aug 2010

GenVec signs new agreement with Novartis for supply of services relating to development materials

GenVec, Inc. today announced a new agreement for the supply of services relating to development materials with Novartis, related to the companies' collaboration in hearing loss and balance disorders. Under this new agreement, GenVec could receive approximately $13 million over four years to manufacture clinical trial material for up to two lead candidates.

7 Aug 2010

Research Roundups: Expanding Medicaid; More spending doesn't reduce mortality; Colonoscopy cost effectiveness; Kids, asthma and access to care

Health Affairs: Little Evidence Of Correlation Between Growth In Health Care Spending And Reduced Mortality - This study examines differences in hospital mortality and cost between 2000 and 2004 for patients at 122 U.S. hospitals, with seven common medical diagnoses: acute myocardial infarction, chronic obstructive pulmonary disease, community-acquired pneumonia, congestive heart failure, cerebrovascular accident (also called ischemic stroke), sepsis, or urinary tract infection.

7 Aug 2010

Need for trained medical professionals to treat medical emergencies in high school athletes

As summer football practice gets into full swing, it's essential to be aware of the risk of exertional heat stroke (EHS) in high school athletes, according to a Safety Alert in The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

6 Aug 2010

GenVec reports net loss of $4.2M for second-quarter 2010

GenVec, Inc. today announced its financial results for the second quarter ended June 30, 2010.

6 Aug 2010

Akonni Biosystems receives patent for TruTip Extraction Kits

Akonni Biosystems, a developer of low-cost, multiplex molecular diagnostic testing systems, today announced that the United States Patent and Trademark Office issued a patent on July 20, 2010 for its method for rapidly purifying nucleic acids. U.S. Patent No. 7,759,112 entitled, "Apparatus, system, and method for purifying nucleic acids" protects the Company's use of its pioneering nucleic acid binding matrix when inserted into a pipette tip, tubing or cartridge for nucleic acid purification. The patent is owned by Akonni Biosystems.

6 Aug 2010

BioCryst second-quarter total revenues increase to $7.6 million

BioCryst Pharmaceuticals, Inc. announced financial results for the second quarter and six months ended June 30, 2010.

5 Aug 2010

CEL-SCI produces and fills first lot of Multikine

CEL-SCI Corporation announced today that it has successfully produced and filled its first lot of Multikine® in preparation for the upcoming pivotal Phase III trial targeting advanced primary head and neck cancer.

5 Aug 2010

Americans stop seeking medical care for recent illness, survey reveals

With unemployment rates remaining at an all-time high, one in five Americans chose not to seek medical care for a recent illness or injury, with four out of 10 citing cost as the primary factor, according to a Deloitte Center for Health Solutions survey of more than 4,000 adults in the United States.

5 Aug 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Sharps Compliance reports revenue of $4.2M for fourth-quarter fiscal 2010

Three-year efficacy data on STELARA for psoriasis presented at American Academy of Dermatology meeting

NIH begins human clinical testing for dengue virus vaccine

H1N1 pandemic could be declared over soon, WHO's Chan says

Study suggests reimbursements can address inappropriate antibiotic usage

Private sleuths take time referring fraud cases to Medicare

Isis second-quarter pro forma net operating loss increases to $15.5 million

First Edition: August 9, 2010

U.S. TSA designates BioStorage Technologies as Certified Cargo Screening Facility

Hemispherx Biopharma second-quarter net loss decreases to $3.67 million

Cornerstone announces ANDA filing for generic Tussionex

Novavax reports net loss of $9.4M for second-quarter 2010

GenVec signs new agreement with Novartis for supply of services relating to development materials

Research Roundups: Expanding Medicaid; More spending doesn't reduce mortality; Colonoscopy cost effectiveness; Kids, asthma and access to care

Need for trained medical professionals to treat medical emergencies in high school athletes

GenVec reports net loss of $4.2M for second-quarter 2010

Akonni Biosystems receives patent for TruTip Extraction Kits

BioCryst second-quarter total revenues increase to $7.6 million

CEL-SCI produces and fills first lot of Multikine

Americans stop seeking medical care for recent illness, survey reveals

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in